Aveir VR Leadless System
ABBOTT MEDICAL · Decision date Mar 31, 2022
What did the FDA approve?
The FDA database entry for P150035 records an approval decision dated March 31, 2022, for the Aveir Leadless Pacemaker, Aveir Delivery System Catheter, and Aveir Link Module. The applicant is listed as Abbott Medical, and the product code is PNJ under the cardiovascular specialty.
The decision statement describes approval for these three named components. The entry does not state whether this action is an original PMA approval or a supplement, and no supplement type or reason is provided. The source does not include clinical data, safety findings, or effectiveness conclusions.
FDA approval order statement
Approval for the Aveir Leadless Pacemaker, Aveir Delivery System Catheter, and Aveir Link Module.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 31, 2022
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150035
- Regulatory pathway
- Premarket approval application
- Applicant
- ABBOTT MEDICAL
- Product code
- PNJ
- Decision code
- APPR
- Decision date
- Mar 31, 2022
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Leadless pacemaker.
- Applicant
- Abbott Medical
- Product code
- PNJ
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P150035 received
Application receipt date recorded by FDA.
P150035 · FDA decision
APPR
P150035/S042 · Related supplement
AVEIR VR Real-World Evidence Study
Timeline entries are records held by MedtechLedger for P150035. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150035
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AVEIR VR Real-World Evidence StudyP150035/S042 | ABBOTT MEDICAL | PMA supplement | Oct 21, 2026 | FDA |
Explore the linked device profile
Other records with product code PNJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Micra Functional Testing on pNGHT and NGHTP150033/S230 | Medtronic, Inc. | PMA supplement | Sep 8, 2026 | FDA |
| Medtronic, Inc. | PMA approval | Apr 6, 2016 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 15900 Valley View Ct., Sylmar, CA, 91342
Sources and methodology
- Original FDA record: P150035
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

